Printer Friendly

BIOPOOL ENTERS INTO DISTRIBUTION AGREEMENT FOR CHINA

 VENTURA, Calif., Feb. 16 /PRNewswire/ -- Biopool International Inc. (NASDAQ: BIPL) announced today that its MeDiTech subsidiary has entered into a distribution agreement with Letrich Industries Ltd. for the distribution of the company's products in The People's Republic of China and Hong Kong.
 Letrich Industries, headquartered in Hong Kong, has two operating offices in The People's Republic of China (PRC). Letrich will promote MeDiTech's products for use on a small semi-automated analyzer which it currently sells in the PRC. Approximately 400 such analyzers were introduced into this market in 1992, with an equal number expected to be sold in 1993.
 "Biopool is very optimistic about the growth potential for the company's products in this new market, especially due to the current large base of installed analyzers in China which will utilize the company's test kits," said Michael D. Bick, Ph.D., chief executive officer. "This potential new market is only now developing, and our ultimate goal is to participate fully in what we believe to be long- term growth potential in a developing market for our products," he added.
 Founded in 1987, Biopool develops, manufactures and markets a full range of test kits to assess and diagnose disorders of blood coagulation, fibrinolysis, platelet function and the vascular system, as well as test kits to determine thrombotic risk factors. The company's products are sold to hospitals and clinical laboratories worldwide.
 -0- 2/16/93
 /CONTACT: Michael D. Bick, Ph.D., CEO, 805-654-0643, or Andrew L. Cerskus, Ph.D., president, 416-332-9419, both of Biopool; or Kim P. Feazle or Roger S. Pondel of Pondel Parsons & Wilkinson, 310-207-9300, for Biopool/
 (BIPL)


CO: Biopool International Inc. ST: California IN: MTC SU:

JL-LS -- LA002 -- 6735 02/16/93 09:06 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 16, 1993
Words:285
Previous Article:CLAIRE'S STORES REPORTS RECORD FOURTH QUARTER EARNINGS, UNAUDITED FULL YEAR RESULTS
Next Article:POST-NEWSWEEK EXPANDS DIGITAL MUSIC EXPRESS(R) AGREEMENT; EARLY AFFILIATE STEPS UP DMX(R) LAUNCH ACTIVITY, SIGNS AFFILIATION PACT
Topics:


Related Articles
BIOPOOL SIGNS LETTER OF INTENT FOR $2 MILLION FINANCING
BIOPOOL TEST KIT POINTS TO t-PA AS INDICATOR FOR HEART ATTACK RISK; HARVARD STUDY PUBLISHED IN LANCET
BIOPOOL NAMES KEITH R. GOULD VICE PRESIDENT-SALES & MARKETING
BIOPOOL RECEIVES FDA APPROVAL FOR THERAPEUTIC DRUG MONITORING CONTROL
BIOPOOL RECEIVES APPROVAL TO MARKET CALIBRATOR FOR USE WITH U.S. DRUG TESTING INC. SYSTEM
BIOPOOL INTERNATIONAL ACQUIRES NEW TECHNOLOGY
BIOPOOL INTERNATIONAL RECEIVES FDA APPROVAL TO MARKET TWO NEW CHEMISTRY REAGENT SYSTEMS
BIOPOOL INTERNATIONAL TERMINATES PROPOSED TRANSACTION WITH SOURCE SCIENTIFIC, INC.
BIOPOOL/XTRANA REPORTS 11% SALES INCREASE AND NET LOSS.
BUSINESS NOTES\Developments.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters